Promethera® Biosciences raises €25.33 million ($31.4 million) in Series C financial round
Mont-Saint-Guibert (Belgium), November 25, 2014 – Promethera® Biosciences today announced the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.
The financing round is supported by existing Promethera® Biosciences investors and two new investors: SFPI-FPIM, the Belgian Federal Holding and Investment Company, and SMS Investments, a Luxemburg based subsidiary office of the German SMS group.
DOWNLOAD THE FULL PRESS RELEASE HERE